Navigation Links
Two Blades Foundation licenses genome engineering technology to KWS
Date:7/9/2012

EVANSTON, Ill., July 9, 2012 /PRNewswire-iReach/ -- Two Blades Foundation (2Blades) has completed a non-exclusive license agreement with KWS SAAT AG (KWS) for access to 2Blades' Transcription Activator Like (TAL) effector code technology for genome engineering in certain crops. 

The TAL code technology is a new method for making highly specific changes in genomes based on novel sequence-specific DNA-binding proteins. TAL effector proteins can be designed quickly and easily to recognize virtually any DNA sequence of interest, enabling the targeting of specific locations in a genome for precise gene replacement and modulation of gene function.  2Blades holds exclusive rights for commercial uses of the technology in plants.  Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in a wide range of plant and non-plant systems.  The use of the TAL code technology in plants will enhance the efficiency and precision of the crop improvement process.

"We're pleased to complete a license with KWS for access to the TAL code technology.  It enables tools that will support their mission of delivering better seed," said 2Blades Chief Operating Officer Diana Horvath.  "KWS joins a growing list of licensees who will implement the technology in their development programs and confer a grant-back of rights to improvements that will aid 2Blades' mission of delivering benefits for subsistence farming in developing countries."  The financial terms of the agreement were not disclosed.

The TAL Code technology was discovered by Ulla Bonas, Jens Boch, Thomas Lahaye, and Sebastian Schornack at Martin-Luther University in Halle, Germany, and was named 2011 Method of the Year by the journal Nature Methods (9:1 doi:10.1038/nmeth.1852). 

The Two Blades Foundation (www.2blades.org) is a 501(c)3 not-for-profit corporation dedicated to developing durable disease resistance in agricultural crops.

Media Contact: Diana Horvath Two Blades Foundation, 847 425 1277, dmh@2blades.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Two Blades Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. A Genetic Approach For Crohns And Colitis Disease Is Financed By The Jeffrey Epstein VI Foundation
2. July is not just about BBQ's; the Arthritis National Research Foundation honors Juvenile Arthritis Awareness Month
3. BIRD - Israel-US Binational Industrial R&D Foundation to Invest $7.15 Million in Eight New Projects
4. Physicians Answer Questions About Food Biotechnology in IFIC Foundation Videos
5. Foundation Venture Capital Group Makes Eighth Start-Up Investment
6. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
7. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
8. Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland
9. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
10. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
11. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology:
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
Breaking Biology News(10 mins):